Lataa...
Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer
BACKGROUND: Neoadjuvant chemoradiotherapy followed by surgery is the primary treatment option for patients with locally advanced esophageal cancer. This multicenter phase I trial examined intratumoral injection of TNFerade biologic, an adenoviral vector that expresses the human tumor necrosis factor...
Tallennettuna:
| Julkaisussa: | Gastrointest Endosc |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543382/ https://ncbi.nlm.nih.gov/pubmed/22520270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gie.2012.01.042 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|